These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15171259

  • 1. Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824.
    Atadja P, Hsu M, Kwon P, Trogani N, Bhalla K, Remiszewski S.
    Novartis Found Symp; 2004; 259():249-66; discussion 266-8, 285-8. PubMed ID: 15171259
    [Abstract] [Full Text] [Related]

  • 2. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.
    Atadja P, Gao L, Kwon P, Trogani N, Walker H, Hsu M, Yeleswarapu L, Chandramouli N, Perez L, Versace R, Wu A, Sambucetti L, Lassota P, Cohen D, Bair K, Wood A, Remiszewski S.
    Cancer Res; 2004 Jan 15; 64(2):689-95. PubMed ID: 14744786
    [Abstract] [Full Text] [Related]

  • 3. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ, Wang X, Kachhap SK, Kato Y, Wei Y, Zhang L, Atadja P, Pili R.
    Cancer Res; 2004 Sep 15; 64(18):6626-34. PubMed ID: 15374977
    [Abstract] [Full Text] [Related]

  • 4. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.
    Romanski A, Bacic B, Bug G, Pfeifer H, Gul H, Remiszewski S, Hoelzer D, Atadja P, Ruthardt M, Ottmann OG.
    Haematologica; 2004 Apr 15; 89(4):419-26. PubMed ID: 15075075
    [Abstract] [Full Text] [Related]

  • 5. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan 15; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

  • 6. Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.
    Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC.
    Clin Cancer Res; 2005 May 01; 11(9):3392-401. PubMed ID: 15867240
    [Abstract] [Full Text] [Related]

  • 7. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.
    Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH, Chen CC.
    Cancer Res; 2008 Apr 01; 68(7):2375-83. PubMed ID: 18381445
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo.
    Weisberg E, Catley L, Kujawa J, Atadja P, Remiszewski S, Fuerst P, Cavazza C, Anderson K, Griffin JD.
    Leukemia; 2004 Dec 01; 18(12):1951-63. PubMed ID: 15496979
    [Abstract] [Full Text] [Related]

  • 9. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines.
    Wang ZM, Hu J, Zhou D, Xu ZY, Panasci LC, Chen ZP.
    Ai Zheng; 2002 Oct 01; 21(10):1100-5. PubMed ID: 12508652
    [Abstract] [Full Text] [Related]

  • 10. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D, Ong JM, Hu J, Desmond JC, Kawamata N, Konda BM, Black KL, Koeffler HP.
    Clin Cancer Res; 2007 Feb 01; 13(3):1045-52. PubMed ID: 17289901
    [Abstract] [Full Text] [Related]

  • 11. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.
    Int J Mol Med; 2008 Nov 01; 22(5):605-11. PubMed ID: 18949380
    [Abstract] [Full Text] [Related]

  • 12. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 13. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ.
    Clin Cancer Res; 2004 Aug 01; 10(15):5271-81. PubMed ID: 15297431
    [Abstract] [Full Text] [Related]

  • 14. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan 01; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 15. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
    Han JW, Ahn SH, Park SH, Wang SY, Bae GU, Seo DW, Kwon HK, Hong S, Lee HY, Lee YW, Lee HW.
    Cancer Res; 2000 Nov 01; 60(21):6068-74. PubMed ID: 11085529
    [Abstract] [Full Text] [Related]

  • 16. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
    Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, Murphy LM, Garrity-Park MM, Shridhar V, Adjei AA, Roberts LR.
    Gastroenterology; 2006 Jun 01; 130(7):2130-44. PubMed ID: 16762634
    [Abstract] [Full Text] [Related]

  • 17. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
    Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA.
    Prostate; 2007 Jul 01; 67(10):1099-110. PubMed ID: 17477369
    [Abstract] [Full Text] [Related]

  • 18. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
    Hwang JJ, Kim YS, Kim MJ, Jang S, Lee JH, Choi J, Ro S, Hyun YL, Lee JS, Kim CS.
    Anticancer Drugs; 2009 Oct 01; 20(9):815-21. PubMed ID: 19644355
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
    Ju R, Muller MT.
    Cancer Res; 2003 Jun 01; 63(11):2891-7. PubMed ID: 12782595
    [Abstract] [Full Text] [Related]

  • 20. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
    Donadelli M, Costanzo C, Faggioli L, Scupoli MT, Moore PS, Bassi C, Scarpa A, Palmieri M.
    Mol Carcinog; 2003 Oct 01; 38(2):59-69. PubMed ID: 14502645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.